Lincoln biotech company gets $750,000 investment

By Matt Olberding, Lincoln Journal Star

A Lincoln-based veterinary biotech company has secured a significant seed investment from local sources.

Thyreos, a vaccine company that is developing a novel vaccine platform that protects against herpesviruses, on Monday announced a $750,000 investment from Invest Nebraska, a nonprofit statewide venture development organization, and unnamed angel investors.